• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗 HLA Ⅱ类抗体与类风湿关节炎相关间质性肺病患者的 C 反应蛋白水平相关。

Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease.

机构信息

HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, 14080 Mexico City, Mexico.

Sección de Estudios de Posgrado e Investigación Escuela Superior de Medicina, Instituto Politécnico Nacional, 11340 Mexico City, Mexico.

出版信息

Cells. 2020 Mar 11;9(3):691. doi: 10.3390/cells9030691.

DOI:10.3390/cells9030691
PMID:32168865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7140697/
Abstract

The pathogenesis of Rheumatoid Arthritis (RA) is not fully understood, probably influenced by genetic and environmental factors. Interstitial Lung Disease (ILD) is an extra-articular manifestation of RA, which contributes significantly to morbidity and mortality. The identification of anti-HLA antibodies has been useful in the transplantation field; however, its contribution to autoimmune diseases as RA has not been fully studied. We aimed to determine the presence of anti-HLA antibodies in RA patients with and without ILD and its possible association with clinical and biochemical markers. One-hundred and forty-seven RA patients, of which 65 had ILD (RA-ILD group), were included. Sera samples for Anti-HLA Class II LABScreen panel-reactive antibodies (PRA) were analyzed. In both groups, women predominated, and lung function was worse in patients with ILD. The anti-CCP+ (UI/mL) was higher in the RA group in comparison to RA-ILD ( < 0.001). Expositional risk factors (tobacco smoking and biomass-burning smoke) were higher in RA-ILD patients. PRA+ was identified in ~25% RA-ILD patients, while ~29% in the RA group. The CRP levels have a positive correlation with the percentage of reactivity (%PRA, = 0.02, r = 0.60) in the RA-ILD group. In conclusion, anti-HLA antibodies correlate with C-reactive protein levels in RA patients with ILD.

摘要

类风湿关节炎(RA)的发病机制尚未完全阐明,可能受遗传和环境因素的影响。间质性肺疾病(ILD)是 RA 的关节外表现,对发病率和死亡率有重要影响。抗 HLA 抗体的鉴定在移植领域很有用;然而,其对 RA 等自身免疫性疾病的贡献尚未得到充分研究。我们旨在确定有无间质性肺疾病的 RA 患者中存在抗 HLA 抗体及其与临床和生化标志物的可能相关性。共纳入 147 例 RA 患者,其中 65 例有间质性肺疾病(RA-ILD 组)。分析了抗 HLA Ⅱ类 LABScreen 面板反应性抗体(PRA)的血清样本。在两组中,女性均占多数,ILD 患者的肺功能更差。与 RA-ILD 相比,RA 组的抗 CCP+(UI/mL)更高(<0.001)。RA-ILD 患者中存在更多的暴露风险因素(吸烟和生物质燃烧烟雾)。约 25%的 RA-ILD 患者和 29%的 RA 组患者检测到 PRA+。RA-ILD 组的 CRP 水平与反应性百分比(%PRA,=0.02,r=0.60)呈正相关。总之,在有间质性肺疾病的 RA 患者中,抗 HLA 抗体与 C 反应蛋白水平相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee1/7140697/6dc61379b2ac/cells-09-00691-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee1/7140697/6dc61379b2ac/cells-09-00691-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee1/7140697/6dc61379b2ac/cells-09-00691-g001.jpg

相似文献

1
Anti-HLA Class II Antibodies Correlate with C-Reactive Protein Levels in Patients with Rheumatoid Arthritis Associated with Interstitial Lung Disease.抗 HLA Ⅱ类抗体与类风湿关节炎相关间质性肺病患者的 C 反应蛋白水平相关。
Cells. 2020 Mar 11;9(3):691. doi: 10.3390/cells9030691.
2
Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.抗瓜氨酸化肽抗体的精细特异性和库扩张与类风湿关节炎相关间质性肺病的关联。
Ann Rheum Dis. 2014 Aug;73(8):1487-94. doi: 10.1136/annrheumdis-2012-203160. Epub 2013 May 28.
3
Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease.靶向肽基精氨酸脱亚氨酶3和4的交叉反应性抗体与类风湿关节炎相关间质性肺疾病的关联
PLoS One. 2014 Jun 5;9(6):e98794. doi: 10.1371/journal.pone.0098794. eCollection 2014.
4
Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease.类风湿关节炎中抗瓜氨酸化蛋白抗体谱:与间质性肺病相关的新自身抗体证据。
Ann Rheum Dis. 2020 May;79(5):587-594. doi: 10.1136/annrheumdis-2019-216709. Epub 2020 Mar 10.
5
Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease.整合肿瘤标志物、炎症指标和疾病活动指标的多维生物标志物方法可能会改善类风湿关节炎相关间质性肺病的预测。
Clin Rheumatol. 2024 Jun;43(6):1855-1863. doi: 10.1007/s10067-024-06984-7. Epub 2024 May 5.
6
Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.血清生物标志物可提高类风湿关节炎-间质性肺疾病的检测率。
Am J Respir Crit Care Med. 2015 Jun 15;191(12):1403-12. doi: 10.1164/rccm.201411-1950OC.
7
Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis.类风湿关节炎中与间质性肺疾病相关的临床和实验室因素。
Clin Rheumatol. 2015 Sep;34(9):1529-36. doi: 10.1007/s10067-015-3025-8. Epub 2015 Aug 9.
8
Risk Factors and Changes of Peripheral NK and T Cells in Pulmonary Interstitial Fibrosis of Patients with Rheumatoid Arthritis.类风湿关节炎患者肺间质纤维化外周 NK 和 T 细胞的危险因素及变化。
Can Respir J. 2019 Dec 1;2019:7262065. doi: 10.1155/2019/7262065. eCollection 2019.
9
Anti-citrullinated alpha enolase antibodies, interstitial lung disease and bone erosion in rheumatoid arthritis.抗瓜氨酸化 α 烯醇化酶抗体、间质性肺疾病和类风湿关节炎的骨侵蚀。
Rheumatology (Oxford). 2018 May 1;57(5):850-855. doi: 10.1093/rheumatology/kex520.
10
Increased incidence of autoantibodies to interleukin-1a in rheumatoid arthritis with interstitial lung disease.类风湿关节炎合并间质性肺疾病患者中白细胞介素-1α自身抗体的发生率增加。
Respirology. 2000 Dec;5(4):315-20.

引用本文的文献

1
Biomarkers of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.类风湿关节炎相关间质性肺疾病的生物标志物:系统评价和荟萃分析。
Front Immunol. 2024 Oct 29;15:1455346. doi: 10.3389/fimmu.2024.1455346. eCollection 2024.
2
A Systematic Review on Biomarkers: Are There Reliable Molecular Biomarkers in Patients With Rheumatoid Arthritis-Associated Interstitial Lung Disease?关于生物标志物的系统评价:类风湿关节炎相关间质性肺疾病患者中是否存在可靠的分子生物标志物?
Cureus. 2024 Aug 8;16(8):e66422. doi: 10.7759/cureus.66422. eCollection 2024 Aug.
3
Therapeutic Approaches for the Treatment of Interstitial Lung Disease: An Exploratory Review on Molecular Mechanisms.

本文引用的文献

1
HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis.HIF1α 抑制促进来氟米特-AHR-CRP 信号通路以减轻 CRP 异常的类风湿关节炎中的骨侵蚀。
Nat Commun. 2019 Oct 8;10(1):4579. doi: 10.1038/s41467-019-12163-z.
2
HLA associations in inflammatory arthritis: emerging mechanisms and clinical implications.炎症性关节炎中的 HLA 相关性:新出现的机制及临床意义。
Nat Rev Rheumatol. 2019 Jun;15(6):364-381. doi: 10.1038/s41584-019-0219-5.
3
Tissue metabolite of type I collagen, C1M, and CRP predicts structural progression of rheumatoid arthritis.
治疗间质性肺病的方法:对分子机制的探索性综述。
Mini Rev Med Chem. 2024;24(6):618-633. doi: 10.2174/1389557523666230816090112.
4
Factors associated with interstitial lung disease in patients with rheumatoid arthritis: A systematic review and meta-analysis.与类风湿关节炎患者间质性肺病相关的因素:系统评价和荟萃分析。
PLoS One. 2023 Jun 23;18(6):e0286191. doi: 10.1371/journal.pone.0286191. eCollection 2023.
5
Peripheral Blood Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Systematic Review.类风湿关节炎相关间质性肺疾病的外周血生物标志物:一项系统评价
ACR Open Rheumatol. 2023 Apr;5(4):201-226. doi: 10.1002/acr2.11535. Epub 2023 Feb 28.
6
Consistency Analysis of 3 Detection Systems for Measuring Serum C-Reactive Protein.三种检测系统测量血清 C 反应蛋白的一致性分析。
Med Sci Monit. 2022 May 11;28:e935171. doi: 10.12659/MSM.935171.
I型胶原蛋白的组织代谢产物C1M和C反应蛋白可预测类风湿关节炎的结构进展。
BMC Rheumatol. 2019 Jan 31;3:3. doi: 10.1186/s41927-019-0052-0. eCollection 2019.
4
High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery.术前高C反应蛋白水平是非肺部手术后间质性肺疾病急性加重的危险因素。
Medicine (Baltimore). 2019 Feb;98(5):e14296. doi: 10.1097/MD.0000000000014296.
5
Innate immune-responses and their role in driving autoimmunity.先天免疫反应及其在驱动自身免疫中的作用。
Autoimmun Rev. 2019 Mar;18(3):306-311. doi: 10.1016/j.autrev.2018.10.005. Epub 2019 Jan 11.
6
TACO and TRALI: biology, risk factors, and prevention strategies.TACO 和 TRALI:生物学、危险因素和预防策略。
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):585-594. doi: 10.1182/asheducation-2018.1.585. Epub 2018 Dec 14.
7
Increased alloreactive and autoreactive antihuman leucocyte antigen antibodies associated with systemic lupus erythematosus and rheumatoid arthritis.与系统性红斑狼疮和类风湿性关节炎相关的同种异体反应性和自身反应性抗人白细胞抗原抗体增加。
Lupus Sci Med. 2018 Sep 25;5(1):e000278. doi: 10.1136/lupus-2018-000278. eCollection 2018.
8
Role of C-Reactive Protein at Sites of Inflammation and Infection.C-反应蛋白在炎症和感染部位的作用。
Front Immunol. 2018 Apr 13;9:754. doi: 10.3389/fimmu.2018.00754. eCollection 2018.
9
Impact of interstitial lung disease on mortality of patients with rheumatoid arthritis.类风湿关节炎患者间质性肺病对死亡率的影响。
Rheumatol Int. 2017 Oct;37(10):1735-1745. doi: 10.1007/s00296-017-3781-7. Epub 2017 Jul 26.
10
A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality.一项基于人群的类风湿关节炎相关间质性肺疾病的队列研究:合并症和死亡率。
Ann Rheum Dis. 2017 Oct;76(10):1700-1706. doi: 10.1136/annrheumdis-2017-211138. Epub 2017 Jun 13.